Monthly Archives: May 2010

The Rise and Fall of the PMU Industry

Posted on May 27, 2010 by

Written by JANE ALLIN Research Analyst | Int’l Fund for Horses Cross-posted from Tuesday’s Horse Page 1 A recent report by Agriculture Canada gives tenuous optimism for the stopping of suffering of the mares and foals at the mercy of … Continue reading →

Posted in Aprela, Pfizer, PMU Industry, Premarin, Wyeth Pharmaceuticals | Tagged , , , , , , , , , , , , | Leave a comment

Pfizer to Withdraw Fablyn NDAs

Posted on May 18, 2010 by

Written by JANE ALLIN Research Analyst | Int’l Fund for Horses Pfizer, the world’s largest drug maker, has announced the withdrawal of its new drug application (NDA) for Fablyn® a selective estrogen receptor modulator (“SERM”) for the treatment of both … Continue reading →

Posted in Aprela, Fablyn | Tagged , , , , , , , , , , , , , , , , | Leave a comment

PMU ranches may be cut to 25

Posted on May 15, 2010 by

Cross-posted from AgCanada Another round of cutbacks may see the number of equine ranches in Manitoba, Saskatchewan and North Dakota slashed to around 25, down from 64 last year. The decline in the local industry that produces pregnant mares’ urine … Continue reading →

Posted in NAERIC, PMU Industry, Wyeth Pharmaceuticals | Tagged , , , , , , , | Leave a comment